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In recent years the number of people using cigarettes in Norway has significantly declined, with 
intake of nicotine being replaced by smokeless tobacco (ST) products such as snus placed in the 
oral cavity. While health risks from smoking cigarettes are well known little is known about 
health risks of using ST. The main aim of this thesis was to compare the effects of oral use of 
snus with nicotine (SN+) and snus without nicotine (SN-) on skin perfusion in the hands and face 
in young habitual users of snus. Skin perfusion was indirectly monitored by measuring changes in 
by skin temperature using infrared thermography. The main findings of this study were a strong 
decrease in skin perfusion in the hands in the SN+ subjects, with little or no effect in the SN- 
controls. SN+ had no effect on the skin temperature of the inner canthus of the eye, which will be 
of interest to those using thermography for fever detection in pandemic screening situations. The 
clear physiological effects of using snus containing nicotine demonstrated in this study justify 
advising patients to avoid using snus containing nicotine prior to surgery and in the immediate 
period after surgery. To my knowledge this study is the first to show the negative effects of SN+ 













It is a well-known fact that cigarette smoking has several different negative effects on health [1]. 
There are approximately 4000 different chemical substances in cigarette smoke and a significant 
amount of these are toxic [2, 3]. Some of these toxic substances are known to influence the 
cardiovascular system, sexual function and lung function [3]. One of the well-known toxic 
substances in cigarette smoke is nicotine, a toxic alkaloid that can be isolated from the tobacco 
plant. The inhalation of cigarette smoke is probably the most known route of administration of 
nicotine. However, there are other routes for the uptake of nicotine in the body, for example 
through the mucosal membrane in the mouth by chewing gum, snuff and snus, or through the 
skin by transdermal plasters.  
 
Over the last decade the use of snus has become increasingly popular in Norway and Sweden, 
especially among the younger generation. This is presumably related to changes in the law that 
made cigarette smoking in public buildings illegal from the year 2004. Because of the increased 
use of snus it is important to be aware of the potential negative health effects that snus may have 
on bodily functions. Snus contains, among other things, nicotine which is known for its addictive 
effects but also for its physiological effect on peripheral circulation [4]. Peripheral circulation can 
be indirectly measured by measuring skin temperature using thermography where the temperature 
of large skin areas of interest can be simultaneously measured with a high degree of accuracy 
using an infrared camera [5, 6].  
 
The aim of this thesis was to evaluate the possible effects snus may have on skin perfusion by 
measuring skin temperature changes following administration of snus after a short period of 
abstinence. It is hypothesized that an effect on skin perfusion may be expected from nicotine 
through its absorption via the mucosal membrane of the oral cavity. The dorsal aspect of the 
hands was selected to represent the main area of investigation. In addition, skin temperature on 
the face was also measured in order to see whether there were local effects on skin perfusion 




upper lip as well as the inner canthus of the eyes since this area is of interest in relationship to 
fever detection using mass screening thermographic systems [7].  
 
Nicotine  
Nicotine is a toxic alkaloid that is found in a family of plants named Nightshades or Solanacae. 
The plant which is used for isolating nicotine for commercial use is the Nicotiana tobacum plant, 
which is named after the French ambassador Jean Nicot in Portugal [8]. It is believed that tobacco 
was sniffed, chewed, eaten and drunk by the Native Americans for medical and ceremonial 
purposes before 1 B.C. [8]. However, tobacco use can be traced back to as early as 1000 B.C., 
with traces of cultivation sites of the tobacco plant in Mexico dating back to 1000-1400 B.C. [9]. 
In 1828 Posselt and Reimann isolated and characterised nicotine as a poison and identified 
nicotine as the main pharmacoactive ingredient in tobacco [9]. The chemical formula was 
discovered in 1843 by Melsens and in 1893 and the first synthetic nicotine was made in 1904 by 
Pictet and Crepieux [9].   
 
In the human body, nicotine resembles the endogenous signal molecule acetylcholine (Ach) (Fig. 
1). Nicotine binds to nicotinic acetylcholine receptors (nAchR) [10]. These receptors are ligand 
gated ion channels and binding of a ligand, that be nicotine or acetylcholine, can lead to 
depolarization of the cell, release of transmitters or gene transcription [11]. Nicotinic 
acetylcholine receptors are found in the central nervous system, throughout the brain on both 
excitatory and inhibitory neurons. Nicotine has the ability to stimulate antagonistic pathways in 
the central nervous system (CNS) through several nAchR subtypes that possess different 
sensitivities to activation and desensitization by nicotine. Stimulation can increase inhibition of 
circuits when excitation is high and increase excitation when circuits are less active [12]. The 
result of this circuit-level integration is that nicotine can modulate behavioral function in a 
bidirectional way [10]. The main target of nicotine is located in the brain where a subfamily of 
nAchR’s are responsible for depolarization and transmitter release when stimulated [12]. The 
released transmitters can be both glutamate (excitatory) and GABA (inhibitory), which makes the 






Fig. 1. The chemical structures of Ach and nicotine respectively. 
 
Nicotine stimulates nAchRs in the mesolimbic dopamine (DA) system which is a central 
mediator of drug reward and reinforcement located in the ventral tegmental area [13, 14]. One of 
the brain areas where the DA system projects to is the nucleus accumbens (NAcc). NAcc is the 
brain’s pleasure centre. Stimulation of the DA system leads to an increase in dopamine release in 
the NAcc which gives a feeling of wellbeing. This is also called the reward circuit. Stimulation of 
the DA system will also greatly attenuate nicotine self-administration [10] as sstimulation leads 
to a positive feedback resulting in a desire to continue the stimulating behaviour (that is using 
nicotine). This mechanism, together with the fact that nicotine stimulation of nAchRs leads to 
synthesis of more nAchRs makes nicotine a highly addictive substance [14, 15]. Nicotine can 
have various behavioural effects in humans and animals since nicotine influences distinct 
neuronal pathways that express different subtypes of nAchRs. Small differences in the activation 
state or sensitivity of neuronal pathways can therefore result in large differences in the 
behavioural responses produced by nicotine among individuals [10].  
 
Nicotine has a half-life of approximately 1-2 hours. Around 1% of the absorbed nicotine is 
excreted by the kidneys and can be detected in the urine, depending on the pH of the urine. 70-
80% is metabolized in the liver to cotinine by Cytochrome P450 2A6 enzymes [16]. Cotinine has 
a longer half-life than nicotine and is further metabolized to trans-3′-hydroxycotinine (3-OH-Cot) 
that has a half-life of 7hours [17]. In order to obtain an accurate level of serum nicotine it is 
necessary to measure the concentration of nicotine in combination with the concentration of these 




Smokeless tobacco -ST 
In recent years cigarette sales have declined in the Western World probably due to more 
awareness concerning the health risks associated with smoking. In addition, the decline may be 
explained by new and more restricted regulations in use and sales of cigarettes. In Norway 
smoking is forbidden in public buildings and tobacco advertising is prohibited. The tobacco 
industry is trying to promote a “new face” for tobacco by developing products that are a less 
health risk choice compared to cigarettes. Smokeless tobacco (ST) is one such product. In 2011, 
25% of  the young people between 18 and 30 years in Norway were smoking, and 31%  reported 
using ST on a daily basis [19]. ST is orally consumed and not burned and this makes its use legal 
in places with anti-smoking regulations. There are a variety of different types of ST products and 
the use of the different types is, to a great extent, linked to geography [8, 20].   
 
In India smokeless tobacco is used by over 25% of the people, with Gutkha being the most 
common [20, 21]. This is an oral ST product and is placed inside the cheek and chewed and the 
salvia is either spat out or swallowed. In America, snuff is widely used. This is a fine grounded 
dry tobacco that is inhaled through the nose. Dipping tobacco is a moist form of snuff which is 
placed between the lower lip and gum, not chewed and the saliva is spat out. Snus is another oral 
smokeless tobacco product which is placed between the lip and gum, without any spitting. The 
traditional Swedish snus is the preferred snus type in the Scandinavian countries including 
Norway. This snus type was developed during the early 1800s. It was made of ground tobacco 
leaves, water, salt and potash, and its composition has hardly changed today. Up to about the 
early 1940s snus was the predominant form of tobacco used in Sweden, until cigarette smoking 
took over in the late 20
th
 century [22]. Snus has never been marketed as a product designed to 
help people to cease smoking although many Scandinavian smokers have replaced cigarettes with 
snus after the health hazards of smoking became clear [22, 23]. There are several differences 
between Swedish- and American snus. American snus has generally lower moisture content, 
American snus having a water content of 15-30% compared to a water content of around 50% in 
the Swedish snus. The placement is normally under the upper lip for the Swedish type and under 
the lower lip for the American type, neither is chewed [24, 25]. The manufacturing processes is 




American type and thus, a higher bioavailability of nicotine [24, 26]. There is on average a higher 
nicotine content in Swedish snus compared to both American snus and cigarettes. 
 
ST produces sympathomimetic effects similar to those produced by cigarette smoking. Smoking 
and ST increase heart rate and epinephrine levels immediately after administration [27] and both 
has been associated with death from cardiovascular disease, cerebrovascular disease and cancer 
[28]. ST-users and cigarette smokers have an increased risk of developing diabetes type 2 after 
long-term use [29]. Nicotine’s action as a sympathomimetic drug is responsible for the increase 
in heart rate and blood pressure seen in ST-users and cigarette smokers [30, 31]. Most current 
studies have focused on the effect of cigarette smoking or ST products in general, with few 
studies designed specifically to look at the effect of snus. In a study by Overland, et al. they 
found  higher levels of high density lipoproteins and higher systolic blood pressure in snus-users 
compared to non-snus users [32].  
 
Snus contains about 2500 different chemical substances compared to 4000 in cigarette smoke 
[33]. The Norwegian health authorities (Helsedirektoratet) states that at least 30 of these 
substances are carcinogenic and 40-50 substances from tobacco have a possible negative 
significance on health [22, 34]. Snus contains a high level of tobacco specific nitrosamines 
although these levels are not as high as in cigarettes [8]. One of these nitrosamines is Cotinine 4-
(methylnitrosamino)-1-(3-pyridyl)-butanol (NNAL) [34], a carcinogenic substance that can be 
used as an exposure biomarker.  Interestingly, when switching from cigarettes to snus there is a 
50 % decrease in urinary NNAL. It is still unclear if a 50% reduction in NNAL in urinary output 
leads to a reduction in cancer [35]. Since 1992 snus has been illegal in the European Union, 
however Sweden is an exception to this rule, and Denmark has a partial exception [33]. The use 
of snus in Norway is legal [4]. The World Health Organization (WHO/Europe) has classified 
snus as carcinogenic and the Norwegian health institute (Folkehelseinstituttet) states that snus is 
as addictive as cigarettes, if not more so [36].  Recently, Swedish snus was launched 
commercially in the USA [19, 32]. In Norway there is a clear trend showing that the use of 




Norway. That amount had increased to 1125 tons in 2008 [37]. In 2013, 14% of Norwegian men 
(16-74 years) used snus compared to 4% of Norwegian women [37].   
 
Snus is chemically basic and the target pH in the production of traditional snus brands is 
approximately 8.5 [22]. This makes the nicotine un-protonated, and thus more easily absorbed by 
the body (higher bioavailability) [15].  Snus is a moist form of tobacco, used as loose grounded 
tobacco or contained in sachets or pouches similar to small teabags [25]. Snus users can obtain 
high plasma concentrations of nicotine [38, 39] and snus users need nicotine plasters with a 
higher dose of nicotine compared to cigarette smokers for successful ST cessation [39]. There are 
large individual differences in the time of use but generally it ranges from 20 minutes to 4 hours. 
The concentration of nicotine may differ from sachet to sachet. The amount of nicotine in each 
portion of snus also depends on the serving size [25]. In contrast to cigarettes, where nicotine is 
taken up by the lungs, nicotine from snus is taken up though the mucous membrane in the mouth 
before entering the blood stream. The absorption of nicotine is slower when absorbed over the 
mucous membrane [33]. An average cigarette contains approximately 9 mg of nicotine while one 
portion of snus (1g) contains 4-18 mg of nicotine, depending on the type and brand. The fact that 
the snus users obtain a higher mean plasma blood concentration of nicotine compared to a 
cigarette smoker [13, 39] is most likely due to the higher concentration of nicotine in snus and the 
duration of use [40].   
 
There are some health benefits associated when switching from cigarettes to smokeless tobacco, 
e.g. decreased risk of lung cancer and less negative effects on the respiratory system [41]. In 
Sweden the use of cigarettes has declined and is the country with the lowest percentage of daily 
smokers in the Scandinavian countries. This is thought as being due to the fact that cigarette 
smokers switch to the less harmful tobacco products such as snus [25]. However, the use of 
smokeless tobacco, including snus is associated with health risk as it can lead to periodontal 
disease, cancer and cerebrovascular and cardiovascular diseases [4, 42]. Nicotine is highly 
addictive and it is hard to refrain from using nicotine once the brain and body has become 
addicted. The withdrawal symptoms of a person who tries to cease using snus are the same as 




does not increase the long term tobacco abstinence period in ST users [42], supporting the finding 
that the overall nicotine exposure in ST users is greater.  
 
Peripheral blood circulation  
The skin is the largest organ of the human body. Its blood supply can change many fold in 
response to thermal requirements. The core of the body is maintained at a more or less constant 
temperature [43]. From a thermoregulatory point of view it is the heat carrying capacity of blood 
and the physiological regulation of blood flow that are important for the heat exchange with the 
environment. In a situation where the body needs to conserve heat, skin blood perfusion is 
dramatically decreased due to vasoconstriction, especially in the acral body parts (hands and feet) 
[44, 45]. When the body needs to loose heat in warm situations or when exercising, heat and skin 
blood perfusion increases dramatically through vasodilatation of the blood vessels in the skin. In 
the cold, blood flow to the skin represents only a few percent of cardiac output whereas in the 
heat this can increase to as much as 30%. The skin surface temperature is determined by the rate 
of heat exchange between the surroundings and the body core [43].  
 
The human skin consists of two layers, the outer epidermis that forms a waterproof barrier and 
the underlying dermis that supports the epidermis. The blood supply to the skin has three major 
functions: 1) Transporting nutrition and oxygen to and removing waste products and carbon 
dioxide from cells, 2) immune defence and 3) the regulation of body temperature 
(thermoregulation). The skin is supplied from two different vascular plexi: the subdermal plexus 
and the superficial plexus. The subdermal plexus is located just below the dermis and branches 
from this plexus supply the superficial plexus, which lies at the junction between the dermis and 
epidermis [46]. There are so called arteriovenous anastomoses (AVAs) in the fingers (in the 
finger tip, under the finger nail), face and other acral parts of the body. This allows 





Most of the skin blood supply is directed to the dermis, with being located in the subcutaneous fat 
layer located below the dermis. The fat layer is a supporting- and isolation-layer for the arteries, 
as well as an energy depot for the body. In the dermis there are many dividing cells that require 
an adequate blood supply for their metabolic needs [46]. The arteries and vessels that are thought 
of as being involved in thermoregulation are located near the surface of the skin and blood 
perfusion in these vessels can be indirectly monitored with thermography [48, 49].  
 
Blood transports heat from the core of the body to the surface of the skin where it is released to 
the surroundings, assuming that the temperature of the surroundings is less than the body 
temperature. In other words, when the blood vessels in the skin vasodilatate and skin blood 
perfusion is increased there is a rise in skin surface temperature. Vasoconstriction of the blood 
vessels will lead to a drop in skin surface temperature. This temperature change can be monitored 
by an infrared (IR) camera. Measuring the skin temperature with an IR camera provides us with 
an indirect measurement of blood flow. That thermography provides us with a reliable indirect 
method for measuring skin blood perfusion has been confirmed in studies comparing 
thermography with other methods for measuring skin blood flow, such as Doppler [50, 51].  
 
Control of peripheral circulation  
The autonomic nervous system (ANS) is part of the peripheral nervous system and is involved in 
involuntary regulatory processes in the body, such as respiration, cardiac regulation, vasomotor 
activity and certain reflex actions [52]. The ANS is divided into the sympathetic and the 
parasympathetic nervous systems which, for the majority of the body’s homeostatic regulatory 
systems, have opposing regulatory functions. In both systems there are normally two connecting 
neurons between their origin and the target organ, the so called pre-ganglionic and post-
ganglionic neurons. The main preganglionic neurotransmitter for both divisions of the autonomic 
nervous system is Ach [53]. This is also the post ganglionic neurotransmitter for the 
parasympathetic nervous system, working at the target organs. For the sympathetic nervous 
system, the post ganglionic neurotransmitter is noradrenalin that acts on adrenergic receptors on 




adrenaline. Nicotine has an effect on this part of the nervous system, stimulating sympathetic 
nerves to release noradrenalin and adrenaline due to its spatial similarities to Ach. Other sedative 
relaxant neurotransmitters like serotonin and -endorphin are also released by the nicotinic 
acetylcholine receptor mechanism and their effects become more apparent at higher dose of 
nicotine [54].  
 
In response to heat and cold stresses thermoregulatory reflexes regulates blood flow to the skin. 
These reflexes exert their effects on the skin circulation through two branches of the sympathetic 
nervous system - a noradrenergic vasoconstrictor branch and a vasodilator branch. The active 
vasodilator system is responsible for most of the vasodilator response to heat stress and can 
increase skin blood flow > 10-fold [55, 56].  
 
Noradrenaline is a neurotransmitter that leads to contraction of the peripheral blood vessels in 
response to cold exposure to the skin. This reaction can also be seen after nicotine administration. 
There is a nicotine-dependent stimulation of the sympathetic system and an inactivation of vagal 
cardiovascular control [57]. Acute smoking causes a marked increase in sympathetic nerve 
activity to the skin and thus cutaneous vasoconstriction [58]. Decrease in skin temperature in the 
hands was reported after smoking a cigarette, possibly due to the effects of nicotine [55]. The 
result was explained by a contraction of peripheral blood vessels leading to a decrease in skin 
perfusion as indicated by a fall in skin temperature seen during thermography. The same effect is 
expected to be seen in those using smokeless tobacco.  
 
Thermometry and physics of heat transduction  
As early as the time of Hippocrates the importance of body temperature in medicine was 
recognised. Wet mud was smeared onto the skin to observe how fast it dried out, the warmer the 
skin, the faster it dried [50]. This was the approach for measuring temperature until the 16
th
 





a subjective skill until Santorio Sanctorius developed the first thermometer in 1611 [50]. The first 
medical thermometer was developed by Dr. Carl Wunderlich in 1868. This thermometer had a 
scale that was limited to around 37 degrees Celsius [50]. Today measuring the body core 
temperature in different bodily cavities such as rectum, oral cavity, ear canal, bladder, 
oesophagus and in the axilla are commonly carried out as part of normal clinical routine. 
Measurements of skin temperature are rarely carried out even though there are many situations, 
as we know from studies employing thermography, were such measurements do provide valuable 
clinical information [60].    
 
Heat transfer to and from the body can occur in four different ways: 1) Conduction, direct contact 
between an object and a heat source. 2) Convection, heat transfer between a solid form and a 
liquid or gas which moves relatively to the solid form. 3) Radiation, exchange of heat by 
electromagnetic energy between objects having different temperatures. 4) Evaporation, 
conversion of liquid in to vapour. The main avenues of heat exchange in a lightly clothed person 
placed in a room at normal room temperature (22-23ºC) are shown in Fig. 2, where 
approximately 60% of the heat loss from the body is by infrared radiation [61, 62]. Both 
convection and radiation are used in remote temperature detection methods [59]. Convection 
from the human body can be visualized by a technique called Schlieren photography. This makes 
use of changes in refractive index and which are made visual by special illumination. This 
technique is mostly used to monitor heat loss in experimental subjects, e.g.  designing clothing 
for people working in extreme physical environments [59]. Heat loss from radiation can be 







Fig. 2. Heat transfer from the human body [63]. 
 
Thermography 





K) emit energy in the form of electromagnetic radiation [43]. These waves are 
called infrared radiation and are not visible to the human eye. Since all objects on earth are above 
absolute zero, all objects emit this radiation called natural or thermal radiation [43]. The 
wavelengths of the infrared spectra are between 700nm-1mm and lie between that of visible light 
and microwaves (Fig. 3).  
 




The intensity of the emitted infrared radiation from an object directly varies with the objects 
surface temperature. Infrared cameras provide us with visible images of the otherwise invisible 
emitted infrared light.  
 
Emissivity 
Emissivity is the ability an object has to emit energy by radiation. The emissive power of an 
object is defined as the heat flux per unit time and reflects the energy it radiates [64]. The 
radiation is compared to the radiation of a so-called perfect black body. A perfect black body is 
an object that absorbs all incident radiation and radiates in a continuous spectrum as described by 
Planck’s law [46]. The energy an object emits depends on its temperature and emissivity, the 
warmer the object the more energy it radiates. The human body has an emissivity coefficient of 
0.98 which is close to the emissivity of a perfect black body (1.0) [54, 65]. Modern infrared (IR) 
cameras have settings which can be adjusted to the emissivity coefficient of the object examined. 
The distance to the object and air humidity are other factors that can influence the readings from 
an infrared camera. Corrections for these conditions can be independently adjusted in modern IR-
cameras.    
  
Radiometric images, sensitivity and colour coding 
An IR camera detects and records the electromagnetic radiation from an object. Through digital 
processing the camera provides a visual display of the amount of electromagnetic radiation 
emitted, transmitted and reflected by an object [65]. Recent advances in digital infrared camera 
technology, including state of the art image analysis software, have greatly improved the 
usefulness of this technology for examining skin blood perfusion. In a fraction of a second it is 
possible to measure skin surface temperatures over large areas to a high degree of accuracy. The 
IR cameras used in this thesis have a high thermal resolution of 0.1°C (methods). 
 
The electromagnetic video signal is a direct measurement of temperature. Modern camera 




radiometric images. The final detail is dependent on the number of thermal sensors contained 
within the camera sensor system, called focal plane arrays. The processed visual images provided 
by IR-cameras are initially processed as grey scale images (from black to white). However, in 
order to make the temperature distribution easier to visualize further digital processing can 
produce coloured images, where the different colours represent different temperatures. For 
medical thermography the International Standards Organization (ISO) recommend that the so-
called rainbow palette should be used (Fig.4), which was also the colour palette used in this study 





C is normally suitable.  
 
 




The use of Infrared thermography or infrared thermal imaging in medicine is called medical 
thermography. This method is based on analysis of skin surface temperatures as a reflection of 
normal or abnormal human physiology using specialized IR-cameras. Today, thermography has 
become one of the most efficient techniques for the study of skin temperature. Modern infrared 
digital cameras employing focal-plane array technology provide a sensitive diagnostic tool for a 
multitude of clinical and experimental situations [67]. Many studies have shown thermography to 
be a useful tool in research as well as being helpful in the diagnosis of various forms of cancer, 
nervous system disorders, metabolic disorders, neck and back problems, pain syndromes, 
arthritis, vascular disorders, and soft tissue injuries, among others [68-72]. Thirty years of clinical 
use and several thousand peer-reviewed studies in the medical literature have established 
thermography as a safe and effective means to examine the human body [73]. This technique is 
completely non-invasive and does not require the use of ionizing radiation or other potentially 




and routinely used at the University Hospital in Northern Norway (UNN) where this study was 
carried out.  
 
In recent years there has been a large interest in using thermography for detecting whether a 
person is febrile or not in a mass screening scenario, for example during a pandemic situation 
[74]. Implementation of pandemic infrared thermographic screening is based on the detection of 
febrile temperatures, usually using the inner canthus of the eyes as the target site. Using 
thermography for fever screening is not without debate and there is some concern about the 
exactness of the relationship between deep body temperature and infrared thermal images of 
selected skin areas on the head [7]. There are few scientific validation studies that have 
specifically carried in this area, most been made on children [7]. To my knowledge there are no 
studies that have specifically examined the effect that nicotine use may have on facial skin 
temperature, especially around the inner canthus of the eye. 
 
Static and Dynamic Infrared Thermography 
There are 2 basic forms of infrared thermal imaging, static and dynamic. In static IR 
thermography a single image is taken [65]. From these images the spatial temperature distribution 
over the area of interest can be measured. The interpretation of such an image depends on the 
temperature distribution over the area. In clinical medicine the distribution of body surface 
temperature is basically symmetrical between the left and right side of the body [75]. The face 
hands, arms, feet and legs show a high degree of thermal symmetry [76, 77]. Clinical 
thermographers often make use of this fact where an asymmetrical thermal distribution between 
two identical skin areas on the left and right side of the body, may indicate a pathological 
condition on one of the sides.  
 
Static thermography gives little information on the dynamics of skin blood perfusion. Dynamic 
infrared thermography (DIRT) is a technique that involves taking a sequence of images over time 
and provides the user with useful clinical information on the dynamics of skin perfusion. The 




cameras the recording frequency is selected by the operator. Some modern IR cameras have 
scanning frequencies as high as 50 Hz. By using DIRT changes in skin temperature can be 
continually monitored and recorded, for example following some sort of intervention such as a 
thermal challenge using fan cooling, water immersion or by applying cold/warm object to the 
skin surface. Alternatively one can monitor dynamic changes in skin perfusion following a 
chemical intervention. This was the form used in this study when monitoring the effect of 





Aim of study  
The main aim of this master thesis was to investigate the effects nicotine has on skin blood 
perfusion using the facial and hand skin as target sites in healthy young subjects when using snus.  
A secondary aim was see whether the temperature of face, in particularly the inner canthus of the 
eye, a facial temperature site normally used in mass screening systems for fever detection is 
affected by snus containing nicotine  
 
Infrared thermography was used to indirectly monitor skin blood perfusion during a period of 
snus use. Infrared thermography has been used in similar studies in the past. For example in a 
study by Miland et. al (2006) the effect of a short period of nicotine abstinence on skin surface 
temperatures was studied. In their study skin blood perfusion changes on the dorsal side of the 
hands was studied in both young and old smokers and non-smokers using thermography and 
thermocouples before, during and after immersing the right hand for 2 min in water at 10°C [55]. 
To my knowledge there are no studies that have used thermography as a technique to evaluate the 
effect snus may have on skin blood perfusion on the hands and the facial skin.   
 
The study was carried out in a special laboratory for thermography (LAB 3) at the Department of 
radiology, University Hospital of Northern Norway (UNN), supervised by Professor James 
Mercer, Medical Imaging Research Group, Department of Medical Biology, Faculty of Health 








In this study 2 experimental protocols were used, a main study, Experimental Protocol 1 (EP1) 
and a follow-up study, Experimental Protocol (EP2). The two protocols employed two slightly 
different experimental setups as described below (Experimental Setup 1 (ES1) for EP1 and 
Experimental Setup 2 (ES2) for EP2). 
 
Subject recruitment  
In the main study (EP1) 15 young healthy volunteers aged between 19 and 32 year (4 males and 
11 females) participated (hereafter referred to as the subjects). They were recruited via Facebook 
or from the University of Tromsø community. Only daily snus users were accepted, with no 
considerations as to how often they used snus, how much snus they used or the nicotine strength 
of the snus. Each subject was subjected to 2 experiments – one in which they received snus 
containing nicotine and a second experiment in which they received snus without nicotine as a 
control experiment. The order of nicotine/no nicotine was randomized and the experiments were 
performed on different days. The subjects were not informed whether they were receiving snus 
with or without nicotine.   
 
The study was approved by the regional committee for medical and health research ethics in 
Northern Norway (Regionale Komiteer for Medisinsk og Helsefaglig Forskningsetikk Nord). The 
participants were informed verbally as well as receiving written information and had to sign a 
consent form before participating in the experiment.  
 
Snus  
The snus used in the experiments was of the Swedish brand Skruf (Skruf sterk #3 – Fig. 5). This 
is a pouched snus with a nicotine content of 8 mg per portion of 1 g. The nicotine free snus was 




both types of snus a single pouch weighted 1 gram. Throughout the remainder of this thesis snus 




Fig. 5.The type of snus used in the experiment A) Skruf Stark #3 with nicotine B) Onico without 
tobacco or nicotine. 
 
 
Infrared cameras (IR cameras) 
Two different infrared (IR) cameras were used in the main study (ES1). One was used for taking 
images of the facial area (FLIR ThermaCAM™ S65 HS, FLIR systems, Sweden)  and one for 
taking images of the dorsal aspect of the hands (FLIR ThermalCAM™ SC645). Both cameras 
have a resolution of 0.1 
o
C. The emissivity of both cameras was set to 0.98. In the follow-up 
study (ES2) only one of the cameras was used (FLIR ThermalCAM™ SC645). 
 
The rainbow palette was used in this study as recommended by the ISO [66]. The images were 
stored on a pc for further analysis. The stored image were processed using image analysing 





Experimental Setup 1-ES1 
The experiments were carried out at different times of the day (08.00-17.00). Room temperature 
could not be independently controlled and was usually between 22°C and 23°C, but on a few 
occasions was as low as 19°C. Air movement within the windowless room was measured at head 
height of the sitting subjects using a sensitive air movement sensor (AirFlow TA-5 Thermal 
Anemometer, AirFlow developments limited, United Kingdom) and found to be less than 0.1 
m/sec.  
 
In ES1 the subjects were dressed in normal indoor clothing and were seated on a chair throughout 
the experiment. During periods when thermal images were not being recorded the subjects were 
allowed to let their hands hang as free as possible without contacting any surface. During the 
short period (ca. 15 sec) when thermal images were being recorded, the hands were positioned 
palms down on a grid made of thin nylon netting strung on a wooden frame (Fig. 6). The nylon 
grid also minimized skin contact with the surface supporting the hands. To provide a constant 
background temperature an electric heating plate which had an even surface temperature of ca 
40ºC was placed 3 cm below the grid. The short period during which the hands were placed on 
the grid avoided unnecessary heating of the hands by the underlying heating plate. During the 
experiments the subjects were able to observe a monitor on which the live thermal images were 
displayed. In this experimental setup both IR cameras were used. One of the cameras was 







Fig. 6. Schematic illustration of Experimental Setup 1. 
 
Experimental Setup 2-ES2 
The setup for ES2 was similar to that described above for ES1 (Fig 7) with the following 
differences. The facial area was not examined and only the temperatures of the dorsal aspect of 
the hands were monitored. 
 
During the entire experimental period (30 minutes) the subjects sat with the hands resting on the 
nylon grid. In the intervals when IR images were not being recorded a thick piece of cloth was 
placed between the palmar surface of the hands and the nylon grid to avoid heating of the hands 
by the underlying warming plate. The cloth was removed during the short periods (ca. 15 sec) 
when IR images were being recorded. In contrast to ES1 the subjects were unable to observe the 






Fig. 7. Schematic illustration of Experimental Setup 2. 
 
In ES1 there were a few occasions when there was some instability in the hospital room heating 
system, especially in the mornings and as a result air temperature fell by a few degrees from the 
normally controlled level of 22-23
o
C. To avoid this problem in ES2 a small heating fan was used 
to raise room temperature back to 22-23°C before the experiment started. The fan was switched 
off before the subject entered the room. No extra heating was employed during the experiment 
and the room temperature remained stable.  
 
Experimental protocol 1 -EP1 
The subjects were asked to abstain from nicotine (snus, cigarettes, nicotine plasters etc.), as well 
as to abstain from using caffeine, alcohol or other stimulants for a minimum period of 4 hours 




asked not to use lotions on the hands or face and to have nails free from nail varnish. The subjects 
were also asked to avoid any cold exposures on the day of the experiment and to refrain from 
washing their hands or face before the experiment. They were required to remain indoors for at 
least 20 minutes before entering the laboratory (stabilization period). The male subjects were 
required to be clean shaven and for both sexes the subjects had to be free from facial jewellery 
such as piercing. Long hair was secured so as not to obscure the facial skin. After the stabilisation 
period the subject received two bags of either Skruf stark # 3 (SN+) or Onico (SN-). The two 
bags were placed by the researcher on the surface of the subjects tongue. The subjects had then to 
use their tongues to place the bags into the position that they routinely used when using snus 
(always under the upper lip).  
 
Each experiment lasted 60 minutes, a 30 min period during which the subjects kept the snus in 
their oral cavities followed by a 30 min recovery period.  After the 30 minutes of using snus, the 
subject spat out the pouches into a bowl that was held up for them. 
 
When recording the facial images the subjects were asked to look directly into the IR camera 
which was positioned at head height across the table in front of them (see Fig. 6). One of the bare 
walls of the room was used as a uniform background for the facial pictures. On the face, skin 
temperatures were analysed from seven differently shaped regions of interest (ROIs): the tip of 
the nose, left and right cheek, the chin, in between the eyes (bridge of nose), around the mouth 












Fig. 8. The seven ROIs used to measure the temperature of the face during the experiment. The 




Fig. 9. The regions of interest (ROI’s) measured on the fingers and the back of the hands. The 




For the hands, dorsal skin surface temperatures were separately analysed for the back of the hand 
and the fingers. The ROI’s used are shown in Fig. 9. For the dorsal surface of the back of the 
hand the average temperature within a polygonal ROI extending from the wrists to the base of the 
digits was used. For the fingers the average temperature along straight lines which extended from 
the tip of the finger (middle of the fingernail) to the base of the finger was used.  With regard to 
the latter, test images prior to the study had revealed that the average temperature along these 
profile lines was very similar when compared to the average temperature within a traced ROI of 
the entire finger.  
 
IR images of the face and hands were recorded at various set time-intervals during the 60 minute 
experiment: at the start of the experiment before SN+ or SN- were given (time-point 0) and at 
time-points 10, 15, 20, and 30 minutes while the person had snus under the lip. Following 









Experimental protocol 2 -EP2 
In the follow-up study 6 young healthy volunteers aged between 19 and 25 year (3 males and 3 
females) were recruited from the University of Tromsø community. In EP2 the subjects were 
asked to use snus with nicotine 4 hours prior to the start of the experiment, with no future use 
before the experiment. During the experiment the subjects were more heavily dressed than in EP1 
in order to ensure that all subjects had warm hands at the start of an experiment with the purpose 
to obtain vasodilatation of the blood vessels. Otherwise the participation requirements used in the 
EP1 were followed.  
 
After the end of the stabilisation period (30 minutes) two bags of SN+ or SN-  were given to the 
subjects as described above for EP1. The subjects were not informed beforehand whether the 
bags of snus contained nicotine or not.  
 
In this follow up study thermal images were only taken of the dorsal aspect of the hands at time-
point 0, before snus and at 5 minute intervals during the 30 minute period in which snus was 
placed under the upper lip (Fig. 11). Temperature measurements were restricted to the dorsal 
aspect of the 10 digits and calculated from straight lines ROI’s as described above for ES1 (see 
Fig. 12).  
 





Fig. 12. The linear regions of interests (ROI’s) measured on the hands in EP2. The temperature 
scale is shown to the right. 
 
Skin temperature calculations  
All statistical calculations were carried out using Excel® (Microsoft Corporation, USA).  
 
Facial temperatures  
In EP1 the average temperature within the seven facial ROI’s for each subject was calculated at 
each time-point. This data was then used to calculate a total average for the 7 ROI’s for each 
subject for each time-point (average of average) for SN+ and SN-. The mean facial skin 
temperature (Tmf) value for the 15 subjects for each time-point was calculated from this data. The 
mean temperature for the ROI in the area around the mouth at each time-point for each subject 
was also calculated. From these values the average for the group was calculated (average of 
average). To test whether facial temperature was affected by nicotine a statistical comparison 
(Student T-test) was made of the mean facial temperature difference between the nicotine and 
nicotine free experiments at all the set time-points in all subjects. The same was done for the 
temperatures measured in the ROI around the mouth. For the ROI covering the inner canthus of 




SN- subjects at the start of the experiment and at the end of the 30 minute period of using snus. 
Student T-test was used for comparing differences and the temperature change after 30 minutes 
of snus (SN+ and SN-). 
 
Hand temperatures  
For the hand skin temperatures the back of the hand and the fingers were analysed separately. For 
the polygonal ROI on the back of the hand the average temperature for each subject at each time-
point (0,10,15,20,30,40,45,50 and 60 minutes after start) was calculated for SN+ and SN-. A 
mean of these values was calculated with SD’s. The mean temperatures along the single line 
ROI’s used for the fingers was calculated in a similar manner. 
 
Statistics  
The statistical analysis was carried out using Excel®, and a hypothesis test based on pooled 
measurements was used to calculate the statistical significance of the results.   
 
The difference in temperature between the experiment with SN+ and SN- for each person for 
each set time-point was used for the statistical analysis. The design of ES1 and ES2 allows each 
subject to be their own control (the control values were the experiment with SN-). The central 
limit theorem assumes that the results (the change in temperature) are (approximately) normally 
distributed [78].  
 
The average temperature change at a given time-point for the group is described as µ and the 
standard deviation for the temperature change is described as . Both of these are unknown in 
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Equation 1.1: estimation of the average temperature difference () 
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Equation 1.2: estimation of the variance (
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Equation 1.3: estimation of standard deviation (SD) 
 
  




          
Equation 1.4: calculation of the statistical t.  
 
From this set of equations the following hypothesis can be formulated 
 
Hypothesis H0: =0 (no change in temperature following intake of snus with nicotine) 





The hypothesis was that there is a significant drop in skin temperature on the face, back of hands 
and fingers in EP1 and in the fingers in EP2.  
 
t -value calculations 
t is the critical value for the statistical t. In this case = 0, 05= 100(1-0.05) % = 95%   
 
In EP1 15 subjects participated thus, t< t= -1.761 (for the sample of 15, that is, 14 degrees of 
freedom). For a sample of 15 persons the t-value needs to be lower than the critical value of -1.76 
for the results to have a certainty of 95%. The estimated temperature change is constant but the 
certainty tells us how likely it is that the temperature change is as a result of using snus.  
 
In EP2 6 subjects participated thus t< t= -1.48 (for the sample of 6, that is, 5 degrees of 
freedom). For a sample of 6 persons the t-value has to be lower than -2.01 for the results to have 







Experimental Protocol 1 
Mean facial skin temperatures  
Example images at different time-points for a single subject from SN+ and SN- experiments are 
shown in Fig.13.The mean facial skin temperature (Tmf) throughout the time-course of the 
experiments in the SN+ and SN- subjects as well as statistical evaluation of the difference 
between the SN+ and SN- subjects at each time-point are presented in Fig 14 and Table 1 
respectively. Tmf at the start of the experiment were practically identical (32.3ºC) in both groups. 
As can be seen in the figure there was a small, but statistically significant increase in Tmf in both 
groups during the first 10 minutes after receiving snus. Thereafter Tmf remained stable throughout 
the remainder of the experiment. At time-points 10, 15, 20 & 30 there was a statistically 
significant difference between the SN+ and SN- values, in all cases the SN+ values being lower 
(Table 1). For all other time-points there were no differences between SN+ and SN-. The time-
points with statistical significant difference between SN+ and SN- subjects are marked with * in 
the graphs.  
 
 






Fig.14. Mean facial skin temperatures (Tmf) ± SD’s, during the time-course of the experiments in 
the SN+ and SN- subject. The dotted line represents the end of snus period (30 minutes). * = 
statistical significant difference in temperature between SN+ and SN-.   
 
 
Table 1. The average difference in Tmf between SN+ and SN- and the standard deviation at the 
different time-points is presented. The t value as calculated from equation 1.4 are shown for each 
time-point. The statistical significant and the statistical insignificant difference in temperature 
are marked with + and - respectively.  
Minutes  
Average difference in facial 
temperature   Standard deviation  t-value 
t < -1,7 (critical 
value 95%) 
0 0.0 0.9 -0.1 - 
10 -0.3 0.6 -2.3 + 
15 -0.3 0.6 -2.2 + 
20 -0.2 0.4 -1.8 + 
30 -0.3 0.6 -1.8 + 
40 -0.3 0.8 -1.2 - 
45 -0.2 0.9 -0.8 - 
50 -0.1 0.8 -0.5 - 












Mean facial skin temperatures  
With nicotine (SN+)
Without nicotine (SN-)





Mean skin temperatures of the mouth area  
 
While there were some differences in Tmf  between SN+ and SN- there were no clear differences 
when each of the 7 ROI’s on the face were examined separately.  Since the snus was placed under 
the upper lip it was suggested that in the SN+ subjects one might see a local effect on skin 
surface temperature in the ROI covering this area. However as can be seen in Fig 15 and Table 2 
this was not the case. For this facial area there were no statistically significant differences in the 




Fig. 15. Mean skin temperatures of the mouth area (Tmm) ± SD’s. The dotted line represents the 
























Table 2. The average difference in Tmm between SN+ and SN- and the standard deviation at the 
different time-points are presented. The t-value as calculated from equation 1.4 are shown for 
each time-point. The statistical significant and the statistical insignificant difference in 
temperature are marked with + and - respectively 
Minutes  
Average difference in 
temperature in mouth ROI  Standard deviation  t-value 
t < -1,7 (critical 
value 95%) 
0 0.3 0.6 2.0 - 
10 0.0 0.5 0.2 - 
15 0.0 0.5 -0.1 - 
20 0.0 0.7 0.2 - 
30 0.1 0.7 0.5 - 
40 0.1 1.2 0.3 - 
45 0.0 1.1 -0.1 - 
50 0.0 1.0 0.0 - 
60 0.0 1.0 0.1 - 
 
  
Maximum mean skin temperature of the inner canthus of the eye  
The maximum mean skin temperatures for the ROI’ covering the inner canthus of the eyes (Tme)  
in the SN+ and SN- subjects at time-points 0 and 30 are presented in Fig 16 and the statistical 
comparisons are shown in Tables 3 and 4.  There was no statistically significant difference 
between the SN+ and SN- subjects at these two time-points. However for both groups there was a 






Fig.16. Mean maximum temperature in the ROI at the inner canthus of the eyes (Tme) at 
timepoint 0 and after 30 minutes of snus for SN+ and SN- subjects with SD’s. 
 
Table 3. Statistical evaluation of differences in Tme at the start and end of the snus period for 
SN+ and SN- subjects with SD’s are presented, with the t-value for each time-point. The 
statistical insignificant difference in temperature is marked with -.  
Minutes  
Average difference 
in temperature  
Standard deviation 
 t-value 







-0.1 0.4 -0.9 
- 
 
Table 4. The average temperature change with SD’s for Tme from the start point and to the end of 
the snus period (30 minutes) for SN+ and SN- with the t-value for SN+ and SN- for the time 
series (0-30), are presented. The statistical insignificant decrease is marked with -.  








0.2 3.5 - 


















Mean maximun temperature in the ROI at the inner 







Hand skin temperatures  
 
Fig.17. IR images of the dorsal side of the hands at different time/points during the snus period 
(0-30 minutes). Upper row: SN+, lower row: SN-.  
 
In Fig. 17 sample IR images of the hands for an individual subject throughout the time-course of 
a single SN+ and a SN- experiment are shown, which give a visual presentation of the pattern of 
temperature changes seen. The decreasing skin temperatures with time in the SN+ subject are 
clearly evident.  
 
Mean skin temperatures for back of the hand 
The mean skin temperature for the back of the hand throughout the time-course of the 
experiments in the SN+ and SN- subjects are presented in Fig 18. The mean skin temperatures at 





respectively). At time-point 30 there was a statistically significant difference between the SN+ 
and SN- values, with the SN+ skin temperatures being lower (0.8ºC) as presented in Table 5 and 
with an * in Fig. 18. For all other time-points there were no differences between SN+ and SN-. In 
the SN+ group there was a statistically significant drop in skin temperature between the start of 
the experiment and time-point 30, when the snus was removed. Furthermore the further drop in 
mean skin temperature after 30 minutes of recovery was also statistically significant. No 
statistical significant change in skin temperature was found for the SN- subjects throughout the 





Fig.18. Mean skin temperatures of the back of the hand (Tmh) ± SD’s for the SN+ and SN- 
subjects. The dotted line represents the end of snus period (30 minutes). *= statistical significant 
difference in temperature between SN+ and SN-.  
 
Table 5. Table 5 the average difference Tmh between SN+ and SN- and the standard deviation at 
the different time-points are presented. The t-value as calculated from equation 1.4 are shown for 
each time-point. The statistical significant and the statistical insignificant difference in 
temperature are marked with + and - respectively.  
Minutes  




t < -1,7 (critical 
value 95%) 
0 0.4 1.0 1.4 - 
10 1.5 2.0 0.8 - 
15 -0.5 1.6 -1.1 - 
20 -0.4 1.6 -1.0 - 
30 -0.8 1.6 -1.9 + 
40 -0.9 2.1 -1.7 - 
45 -0.9 2.2 -1.5 - 
50 -0.9 2.2 -1.6 - 























Mean finger skin temperatures 
Mean finger skin temperature (Tms) for the back of the fingers throughout the time-course of the 
experiments as well as the statistical evaluation of the difference between the SN+ and SN- 
subjects at each time-point are presented in Fig 19 with the time-points with statistical significant 
difference between SN+ and SN- subjects marked with an * and in Table 6 respectively. Mean 
finger skin temperature at the start of the experiment in the two groups were practically identical 
(32.8ºC). In the SN+ subjects there was a statistically significant drop in temperature already 
after 10 minutes. This trend continued and after 30 minutes Tms had fallen by 2.8ºC. In the SN- 
groups there were no statistically significant changes during the same period. In both groups 
finger skin temperature fell during the recovery period (1.7°C and 0.9°C for the SN- and SN+ 
groups respectively), this fall only being  statistically significant for the SN- group (Table 7).  
 
Fig.19. Mean skin temperatures of the fingers (Tms) in SN+ and SN- subjects. The dotted line 
represents the end of snus period (30 minutes). *= statistical significant difference in temperature 
























Table 6. the average difference in Tms between SN+ and SN- and the standard deviation at the 
different time-points is presented. The t-value as calculated from equation 1.4 are shown for each 
time-point. The statistical significant and the statistical insignificant difference in temperature 
are marked with + and - respectively.  
Minutes  
Average difference in 
temperature Standard deviation  t-value 
t < -1,7 (critical 
value 95%) 
0 -0.1 2.1 -0.2                             - 
10 -2.0 3.4 -2.3 + 
15 -2.2 3.2 -2.7 + 
20 -2.4 3.2 -2.8 + 
30 -2.8 3.6 -2.9 + 
40 -2.5 4.5 -2.2 + 
45 -2.5 4.6 -2.1 + 
50 -2.5 4.2 -2.2 + 
60 -2.0 4.4 -1.8 + 
 
 
Table 7.  The statistical significant decrease in Tms with SD’s for snus period (0-30 minutes) and 
the recovery period (30-60 minutes) are represented for SN+ and SN-. Statistically significant 
and insignificant decrease in Tms are marked with + and - respectively.  
 
Average change in 
temperature 
Standard 
deviation  t-value 
t < -1,7 (critical 
value 95%) 
With nicotine 
   
 
0-30 (snus period) -2.1 2.7 -3.0 + 
30-60 (recovery) -0.9 2.1 -1.6 - 
Without nicotine 
   
 
0-30 (snus period) 0.5 2.6 0.8 - 
30-60 (recovery) -1.6 1.9 -3.2 + 
 
Experimental Protocol 2  
The mean skin temperature for the back of the fingers (Tms) throughout the time-course of the 
experiments as well as the statistical evaluation of the difference between the SN+ and SN- 
subjects at each time-point is presented in Fig 20 and Table 8 respectively. The mean skin 






C for SN+ and 34.0
o
C for SN-). Throughout the time-course of this experiment there was a 
statistically significant difference between SN+ and SN- subjects only at time-points 20 and 25. 
 
The decrease in Tms from time-point 0 to time-point 25 for the SN+, subjects was statistical 
significant, although not at time-point 30. A small but statistically insignificant increase in skin 
temperature of the fingers can be seen in the SN- subjects throughout the first 25 minutes of 




Fig.20. The mean skin temperature (Tms) of the fingers during the time-course of the experiments 

























Table 8 the average difference in Tms between SN+ and SN- and the standard deviation at the 
different time-points is presented. The t-value as calculated from equation 1.4 are shown for each 
time-point. The statistical significant and the statistical insignificant difference in temperature 
are marked with + and - respectively.  
Minutes  
Average difference in 
temperature  Standard deviation  t-value 
t < -2,0 (critical 
value 95%) 
0 -0.1 0.3 -0.7 - 
5 -1.1 2.0 -1.3 - 
10 -1.6 2.1 -1.9 - 
15 -1.9 2.7 -1.7 - 
20 -2.2 2.0 -2.7 + 
25 -2.4 2.3 -2.5 + 
30 -1.7 2.5 -1.7 - 
 
 
Table 9. The statistical significant average difference in Tms with SD’s during the time series; 0-
25 minutes and 0-30 minutes for SN+ and SN-. Statistically significant and insignificant decrease 
are marked with + and - respectively. 
 
Average difference 
in temperature  Standard deviation t-value 
t < -2,0 (critical 
value 95%) 
With nicotine         
   0-25 -1.3 1.5 -2.1 + 
0-30 -1.1 1.5 -1.7 - 
Without nicotine 
   0-25 0.8 1.1 1.9 - 








In this study the effect of nicotine uptake over the oral mucosa on skin perfusion of the face and 
hands of young healthy habitual users of snus containing nicotine has been studied. The results 
show that skin perfusion decreased when using snus, presumably through the effect of nicotine. 
While this finding was not unexpected due to the well documented effects of nicotine uptake 
through smoking [1, 79], to my knowledge this is the first study in which such an effect has been 
demonstrated through the oral administration of nicotine by using snus. In the following sections 
the results of the two protocols used, EP1 and EP2, will be individually discussed. This is 
followed by a more general discussion of the study 
 
 
Experimental Protocol 1 
Facial skin temperatures  
In EP1 oral uptake of nicotine caused a small but statistically significant difference in Tmf 
between the SN+ and SN- subjects, with Tmf being lower in the SN+ group during the period in 
which snus was in the oral cavity. However, it is difficult to draw a firm conclusion concerning 
the effect that snus containing nicotine has on Tmf since the results are confounded by the 
statistically significant 0.6ºC increase in Tmf in both the SN+ and SN- subjects during the first 10 
minutes of the experiments. The subjects Tmf was actually higher at all other time-points 
compared to the start temperature in both SN+ and SN- experiments.  
 
Mean facial skin temperature was determined by averaging skin temperature values from 7 
different ROI’s and it is important to keep in mind that there may be local differences in facial 
skin temperatures [80]. Local variations in facial skin temperatures were also found in this study. 
For example the largest increases during the initial 10 minutes of the experiments were found on 
the cheeks and nose. These local variations in skin temperature values in the individual ROIs 
provide information that allows one to suggest some tentative explanations for the increase in Tmf 





First, snus can be regarded as being an irritant, causing severe reactions in the oral mucosa 
resulting in oral lesions and activation of the immune system at the mucosal area in contact with 
the snus [81, 82]. Since it is known that other irritants such as capsaicin and menthol applied to 
the mucosal tissue in the oral cavity cause an increase in facial skin blood flow [83] it is 
speculated that this may be, at least, partially responsible for the observed increases in Tmf during 
the first 10 minutes. A second tentative explanation relates to local reflexes affecting mucosal 
circulation, caused by having an object placed in the oral cavity. Increases in mucosal circulation 
are known to be initiated, for example, when drinking or eating [84] which may also occur when 
using snus. A third, and perhaps, more plausible explanation may be that the equilibration period 
prior to the start of the experiments was too short. In this study the experiments were carried out 
in the winter months in Northern Norway and the subjects would be subjected to cold outside air 
temperatures prior to coming to the experimental laboratory. Even though the minimum 
equilibrium period in EP1 was 20 minutes, this period may have been too short. Evidence of this 
can be seen from the skin temperatures on the tip of the nose and the cheeks. The skin 
temperatures of the tip of the nose were on average 1-2
o
C lower than the 6 other ROI’s at the 
starting point (time-point 0). The low nose temperature strongly affects the Tmf values for the 7 
combined ROIs at the start of the experiment. The nasal vasculature has many arteriovenous 
anastomoses (AVAs) [85] which are normally closed at room temperature in normothermic 
subjects, causing the nose to appear as a relatively cold area compared to other facial areas [85]. 
After entering a warm environment the AVAs will slowly open, although to have fully open 
AVAs most subjects need to be slightly hyperthermic, for example during strenuous exercise 
[86]. It is suggested that in EP1 the subjects simply had too little time for the AVAs to become 
adapted to the room temperature in the laboratory. The cheek skin temperatures were also 
approximately 1
o
C lower at the start of the experiment compared to other facial sites and perhaps, 
for similar reasons, had not fully equilibrated to the ambient temperature of the laboratory at the 
time-point when snus was administered.  
 
One could speculate that the placement of nicotine under the upper lip may affect the temperature 
of the overlying skin area. However, the changes in mean skin temperatures for the ROI covering 




differences between SN+ and SN- (Fig.14), indicating that the placement of snus under the upper 
lip had no clear local effect on skin temperature 
 
As mentioned in the introduction the temperature of the inner canthus of the eyes is regarded as 
being one of the warmest skin temperature sites on the face. It is for this reason that this facial 
area has attracted the attention of those interested in using thermography for fever detection in 
mass screening situations, for example at airports. This study showed that there was a statistically 
significant increase in the temperature of the inner canthus at the end of the 30 minute period 
during which snus was in the oral cavity however, the increase occurred in both the SN+ and SN- 
subjects. Furthermore, there were no statistically significant differences between the SN+ and 
SN- subjects in the maximum skin temperature measured at either the start or the end of the 
experiment. It is therefore concluded that snus containing nicotine has no clear effect on the 
temperature of the inner canthus of the eyes, at least under the conditions used in this study. 
 
Hand skin temperatures  
When considering the mean skin temperatures of the hands in EP1 (also for EP2) an influence 
of the heating plate (40ºC) that was positioned below the nylon grid in order to ensure a uniform 
background temperature in the IR images (Fig 6 and 7) needs to be considered. Although the 
heating plate was situated 3 cm below the hands resting on the grid it could potentially cause a 
slight heating of the palmar sides of the hands, thus influencing the results. However, it is felt that 
this effect was negligible due to the short period of time that the palmar skin was actually 
exposed to the heating plate, which was limited to ca. 15 sec periods when an IR image was 
being taken. In addition, it is assumed that if the hands were slightly heated by the warm plate 
this this would cause a common error for both the SN+ and SN- experiments. 
 
In comparison to Tmf the vasoconstrictive effect of nicotine intake using SN+ was very evident 
for the hands. This effect was more pronounced on the fingers (Fig. 19) compared to the back of 
the hand (Fig. 18). Interestingly, the time-course of the changing pattern of hand skin temperature 
caused by the nicotine is very similar to that seen when a warm hand is exposed to cold. In such a 
situation the fingers also show the greatest fall in skin temperature [87]. This temperature fall is 




For the back of the hand the fall in skin temperature during the period in which the snus was in 
the oral cavity only became statistically significant at time-point 30, the end of the snus period. 
The skin temperature on the back of the hand in the SN- group changed very little throughout the 
entire experiment while for the SN+ group Tmh not only fell during the snus period but continued 
to fall during the recovery period. The temperature fall in the snus period, up to time-point 30, 
and in the recovery period can only be described as a trend since at none of the time-points in this 
period was there a statistically significant difference between the SN+ and SN- subjects. Since it 
is known that the half-life of nicotine is 1-2 hours it is speculated that the trend of falling 
temperatures in the recovery period may have been due to the continuing effect of nicotine on the 
blood vessels [89, 90]. Such a trend may be more pronounced in users of snus compared to 
cigarette smoking since they are reported to have a higher plasma blood concentration of nicotine 
and cotinine [38].  
 
The vasoconstrictive effect of nicotine was most evident on Tms and it is postulated that this 
vasoconstrictive effect was exerted on the AVAs as well as on other blood vessels in the fingers. 
As is known from sympathetically mediated responses to cold exposure [47] a vasoconstriction of 
the AVAs will have a strong effect on finger skin temperature, considering their role in 
thermoregulation. The AVAs in the fingers, which are primarily located at the tip of the finger, 
below the finger nails, consist of short direct connections between the terminal arteries and veins 
[91]. The AVAs have a rich supply of sympathetically controlled smooth muscle. In a hot 
environment a withdrawal of the sympathetic activity will cause the opening of the AVAs which 
allows rapid arterial blood supply to the veins. As a result the arterial blood supply to the finger 
tips increases as well as the venous return from the fingertips. In fully vasodilatated subjects the 
opening of the AVAs is easily visible in the IR-images due to its effect on skin perfusion, where 
this area shows up as the warmest areas on the fingers. The opposite occurs when subjects need 
to conserve heat, as in the cold, when sympathetic input is at its maximum and these connections 
are fully closed. In many of the SN+ subjects in this study a clear temperature fall at the finger 
tips could be seen, an example of which can be seen in Fig. 17. 
 
Ideally it was hoped at the start of each experiment that all subjects would be in a similar 




was not the case in EP1 and, although the mean skin starting values in the SN+ and SN- subjects 
were similar, the standard deviation was quite large at the starting point. Despite the large SD’s, 
not only at the start of the experiment but at all other time-points, Tms fell by nearly 3°C for the 
SN+ group during the 30 minutes of snus compared to the SN- which had almost an 0,5
o
C 
increase in the same period.   
 
In this study the average temperatures along lines drawn on the fingers were used to calculate 
Tms. In pilot experiments it was shown that this method of calculating Tms gives a very similar 
result to the average temperature determined by drawing a polygonal ROI that covers the entire 
finger. There are several advantages of using the average temperature along a straight line 
compared to a polygonal ROI. Firstly it is easier and less time consuming to draw a straight line 
than constructing a polygonal ROI. Secondly, it reduces the chance of including part of the 
background temperature in the calculations when drawing the line close to the edge of the finger. 
Thirdly, it also reduced the chance of including inaccurate temperature data from the edge of a 
curved object, such as the fingers. This is important since the temperature measuring accuracy of 
an IR- camera become uncertain along the border lines of rounded objects. It should be also noted 
that the straight line ROIs on the finger also covered the finger nail, an area that strictly speaking 
can not be included in true skin temperature. There is little information on emissivity values for 
human nails although there are studies that show human skin and nails have similar thermal 
diffusivity [92]. Since the temperature under the nailbed is greatly influenced by AVA’ activity it 
was decided to include the nail in the measurements. 
 
The continuing fall in Tms following removal of the snus in both the SN+ and SN- subjects during 
the recovery period is not fully understood. It is proposed that there are two possible factors 
which can be involved, a) air temperature/general thermal state of the lightly clothed subjects and 
b) a slow washout of the nicotine from the blood stream after removal of snus as mentioned for 
the skin temperatures for the back of the hand. A similar finding was also seen for Tmh of the 
back of the hands in the SN+ subjects. In support of the former suggestion  it was noticed that 
room temperature was as low as 19
o
C on some of the days when the experiments were performed 
while on other days room temperature was between 22 -23°C. It is postulated that in the lightly 




causing the continuing fall in Tms during the recovery period. Indeed, some subjects reported 
feeling slightly chilly at the end of the experiment compared to the start of the experiment. The 
fact that SN- subjects and not SN+ subjects showed a statistically significant decrease in mean 
skin temperatures in the fingers during the recovery period, support the notion that extraneous 
factors, such as cold air temperature were responsible for the temperature decrease in the 
recovery period. Despite a possible effect due to slightly low room temperature it is interesting to 
note that in the recovery period the skin temperature values in the SN+ subjects were, at all time-
points lower than in the SN- subjects, clearly indicating the vascoconstrictive effect nicotine has 
on skin blood vessels.  
 
In summarising the findings from EP1it is clear that there were some shortcomings in regard to 
the protocol and experimental setup. While the overall effects of nicotine uptake using snus were 
as expected, the fact that there was no rise in temperature in the recovery period was unexpected. 
The results of EP1 indicate that the central vasomotor regulation from the hypothalamus through 
negative feedback regulation may have been influenced by peripheral cold sensors. It should also 
be noted that the SD’s in EP1 were large for each time-point.  These results gave rise to the 
question as to whether the results would have been different if the subjects had not been slightly 
cold stressed and if they had a more similar skin temperatures at the start of the experiment. It 
was for these reasons that it was decided to carry out the follow up study with a slight different 
experimental protocol (EP2). 
 
Experimental Protocol 2  
The design of EP2  using more warmly dressed subjects at air temperatures between 22-23ºC was 
to ensure that all subjects were vasodilatated at the start of each experiment, in the hope that this 
might eliminate the putative cold input effect described above and thereby reduce the large SD’s 
found in EP1. The fingers, rather than the back of the hand, were selected for investigation due to 
the strong effect SN+ had on skin perfusion in this area in EP1. The notion was that if there was 
to be an effect of nicotine in the more vasodilatated subjects, this would be clearly seen in the 




would be even more pronounced than in EP1. A further difference in EP2 was that the subjects 
were not allowed to observe the computer monitor on which the live thermal images were 
displayed. While this approach clearly reduced the standard deviation in both the SN+ and SN- 
subjects at the start of the experiment, the overall results of EP2 were similar to EP1 although the 
drop in mean skin temperature in the SN+ subjects was slightly less than that observed in the 
SN+ subjects in EP1. The number of subjects who participated in EP2  was small (6) and it is 
speculated that this is, at least part, of the reason that the vasoconstrictor effects of SN+ were not 
as pronounced as was hoped.  
 
Despite these small differences the overall findings of EP1 and EP2 are similar and show that 
snus containing nicotine has a powerful effect on skin perfusion, especially in the hands. This 
response is very similar to the effect of nicotine from cigarette smoking. 
 
General  
In this study there were 15 and 6 participants in EP1 and EP2 respectively and, due to these small 
numbers, caution must be applied in drawing conclusions on the effects of SN+. However, 
despite the low number of subject used in this study there was a marked negative effect on 
peripheral circulation. It is therefore felt justifiable to recommend further in-depth investigations 
comparing different age groups and subjects with different habits regarding the amount and 
frequency of snus usage to better characterize these findings.  
 
Recent studies have shown that surgical site infections occur more frequently in smokers 
compared to non-smokers [93]. The infections may be explained by a compromised skin 
perfusion in the operated area by nicotine and carbon monoxide. In plastic surgery patients are 
often advised to stop smoking three months in advance of the scheduled operation to reduce the 
risk for postoperative wound infections.  A negative effect on blood perfusion of the skin could 
lead to a higher risk for postoperative wound healing complications. Plastic surgical operations 
where skin perfusion becomes compromised due to wide skin undermining, such as occurs in 
abdominoplasties or in free flap surgery are at special risk [94]. As one of the conclusions of this 




that the negative effect that snus containing nicotine has on peripheral skin perfusion as 
demonstrated in this study justify advising patients to avoid using snus containing nicotine prior 
to surgery and in the immediate period after surgery. 
 
The absorption of chemical substances over of mucosal tissue is well known. While,  the mucosal 
layer of the lungs are only used for administration of substances in patients with pulmonary 
diseases like asthma and emphysema, the oral cavity, rectum and nose are more commonly used 
sites for administration of a wide variety of drugs. When a drug is absorbed directly from the oral 
cavity the absorption is fast. The drug avoids rapid metabolism in the liver and the low pH in the 
stomach [11]. For example, sublingual administration of nitroglycerine for angina treatment is 
very common. This ease of uptake via the oral mucosa provides an ideal site for nicotine uptake, 
and is one of the appealing aspects for achieving a desired nicotine effect using snus. 
 
Snus contains many other chemical substances besides nicotine[33] and many of these are 
carcinogenic[34]. These chemicals may also be absorbed through the mucosal membrane in the 
oral cavity together with nicotine, and benefit from the fast absorption with high bioavailability 
of the substance in the body. One of the reasons for the rapid absorption may be the high 
vascularity on the oral mucosa. This study showed that the area around the mouth has a high skin 
temperature. Such may reflect the high vascularity of the oral area. 
 
While it is suggested that the main peripheral effects of nicotine are due to stimulation of the 
sympathetic nervous system, such effects may also be due to nicotine’s interactions with nicotinic 
receptors on visceral sensory nerves. It is thought that this action of nicotine is critical for the 
cardio-vascular effects of nicotine use [95]. Previous studies have shown that nicotine causes a 
decrease in skin temperature when injected intravenously at low doses, comparable to those 
obtained by self-administration [96].  
 
Nicotine interacts with nAchR’s in the CNS which is responsible for the addictive nature of 
nicotine. As is known for many substances nicotine use can lead to a desensitization of its 
receptors, nAchR. After prolonged use of nicotine the molecular and physiological reaction from 




this study where some of the subjects had a large decrease in temperature when given SN+ while 
in other subjects the decrease was small. The subjects with the lowest decrease were those 
reporting a high SN+ consumption. One can speculate if a person that had never used nicotine  
previously were to  use the same amount of snus as the subjects in this study  that one would 
expect a stronger physiological response compared to the response seen in habitual SN+ users. 
Nicotine poisoning or “nicotine shock” can be seen in persons unfamiliar to nicotine. Some of the 
symptoms are nausea, dizziness increased heart rate and a feeling of being cold while sweating, 
and can occur in habitual nicotine users as well as first time users [33, 98] .   
 
 
There is a decreased risk in developing cardiovascular diseases, cancers (upper aerodigestive, 
pancreatic, bladder, renal and lung) and developing diseases in the respiratory system when 
switching from cigarettes to snus [41].  On the other hand snus contains many other chemical 
substances besides nicotine [33] and, as already mentioned, many of these are carcinogenic [34]. 
For example, there is evidence of snus having negative effect on cardiovascular health [32] and 
snus users have about twice the risk of pancreatic cancer compared with never-tobacco users  
[99]. A health hazard from SN+ is significant in those that would otherwise not use tobacco in 
any form [100]. The impact of snus containing nicotine on cancer in the oral cavity is still a 
matter of discussion [34, 101, 102].  The direct contact of carcinogenic substances with the oral 




In summary, the main finding in this thermography based study is the demonstration of a strong 
decrease in skin perfusion through the uptake of nicotine in snus, presumably due to the 
vasoconstrictive effect of nicotine. While similar responses are known from cigarette smoking, to 
my knowledge this study is the first to show this for habitual users of snus containing nicotine. A 
secondary finding is that nicotine uptake in users of snus has no effect on the skin temperature of 
the inner canthus of the eye, which will be of interest to those using thermography for fever 
detection in pandemic screening situations. The clear negative physiological effects of using snus 




containing nicotine prior to surgery and in the immediate period after surgery. In this study the 
number of participants was small and further studies comparing different age groups and subjects 
with different habits regarding the amount and frequency of snus usage are needed to shed more 







1. Zhu, B.Q. and W.W. Parmley, Hemodynamic and vascular effects of active and passive 
smoking. Am Heart J, 1995. 130(6): p. 1270-5. 
2. Nordqvist, C. What Chemicals Are In Tobacco Smoke? What Is Cigarette Smoke? 2011  
[cited 2014 01.05]. 
3. National Cancer Institute 2011  [cited 2014 01.05]. 
4. (SCENIHR), S.C.o.E.a.N.I.H.R. Health effects of smokeless tobacco products. 2008  
[cited 2014 01.05]. 
5. Schlager, O., et al., Correlation of infrared thermography and skin perfusion in Raynaud 
patients and in healthy controls. Microvasc Res, 2010. 80(1): p. 54-7. 
6. Awwad, A.M., et al., The effect of temperature on blood flow in island and free skin flaps: 
an experimental study. Br J Plast Surg, 1983. 36(3): p. 373-82. 
7. Mercer, J.B.a.R., E.F.J, Fever screening and infrared thermal imaging: concerns and 
guidelines. Thermology International 2009. 19(3): p. 3. 
8. Melikian, A.A. and D. Hoffmann, Smokeless tobacco: a gateway to smoking or a way 
away from smoking. Biomarkers, 2009. 14 Suppl 1: p. 85-9. 
9. Nordqvist, C. What is nicotine. 2014  [cited 2014 24.02]. 
10. Picciotto, M.R. and P.J. Kenny, Molecular mechanisms underlying behaviors related to 
nicotine addiction. Cold Spring Harb Perspect Med, 2013. 3(1): p. a012112. 
11. Dale, H.P.R.a.M.M., Pharmacology. Seventh ed. 2012, London: Elsevier  
12. Picciotto, M.R., Nicotine as a modulator of behavior: beyond the inverted U. Trends 
Pharmacol Sci, 2003. 24(9): p. 493-9. 
13. Koob, G.F., Drugs of abuse: anatomy, pharmacology and function of reward pathways. 
Trends Pharmacol Sci, 1992. 13(5): p. 177-84. 
14. Mansvelder, H.D. and D.S. McGehee, Cellular and synaptic mechanisms of nicotine 
addiction. J Neurobiol, 2002. 53(4): p. 606-17. 
15. Tomar, S.L. and J.E. Henningfield, Review of the evidence that pH is a determinant of 
nicotine dosage from oral use of smokeless tobacco. Tob Control, 1997. 6(3): p. 219-25. 
16. H. Z. Ring, X.J.L., C.F. Thorn, N. L. Benowitz. Nicotine Pathway, Pharmacokinetics. 
2012  30.04.2014]. 
17. Zevin, S., P. Jacob, 3rd, and N. Benowitz, Cotinine effects on nicotine metabolism. Clin 
Pharmacol Ther, 1997. 61(6): p. 649-54. 
18. Hukkanen, J., P. Jacob, 3rd, and N.L. Benowitz, Metabolism and disposition kinetics of 
nicotine. Pharmacol Rev, 2005. 57(1): p. 79-115. 
19. Larsen, E., J. Rise, and K.E. Lund, Risk and protective factors of adolescent exclusive 
snus users compared to non-users of tobacco, exclusive smokers and dual users of snus 
and cigarettes. Addict Behav, 2013. 38(7): p. 2288-94. 
20. 3rd International Conference on Smokeless Tobacco Advancing Science & Protecting 
Public Health. 2002. 
21. The Tobacco Atlas.  [cited 2014 24.02]. 
22. Rutqvist, L.E., et al., Swedish snus and the GothiaTek(R) standard. Harm Reduct J, 2011. 
8: p. 11. 
23. Lund, K.E., A. McNeill, and J. Scheffels, The use of snus for quitting smoking compared 




24. Piano, M.R., et al., Impact of smokeless tobacco products on cardiovascular disease: 
implications for policy, prevention, and treatment: a policy statement from the American 
Heart Association. Circulation, 2010. 122(15): p. 1520-44. 
25. Foulds, J., et al., Effect of smokeless tobacco (snus) on smoking and public health in 
Sweden. Tob Control, 2003. 12(4): p. 349-59. 
26. Foulds, J. and H. Furberg, Is low-nicotine Marlboro snus really snus? Harm Reduct J, 
2008. 5: p. 9. 
27. Wolk, R., et al., Hemodynamic and autonomic effects of smokeless tobacco in healthy 
young men. J Am Coll Cardiol, 2005. 45(6): p. 910-4. 
28. Henley, S.J., et al., Two large prospective studies of mortality among men who use snuff 
or chewing tobacco (United States). Cancer Causes & Control, 2005. 16(4): p. 347-358. 
29. Ostenson, C.G., et al., High consumption of smokeless tobacco ("snus") predicts 
increased risk of type 2 diabetes in a 10-year prospective study of middle-aged Swedish 
men. Scand J Public Health, 2012. 40(8): p. 730-7. 
30. Benowitz, N.L., Cigarette smoking and cardiovascular disease: pathophysiology and 
implications for treatment. Prog Cardiovasc Dis, 2003. 46(1): p. 91-111. 
31. Benowitz, N.L., P. Jacob, 3rd, and L. Yu, Daily use of smokeless tobacco: systemic 
effects. Ann Intern Med, 1989. 111(2): p. 112-6. 
32. Overland, S., et al., Snus use and cardiovascular risk factors in the general population. 
The HUNT3 study. Addiction, 2013. 
33. Helsedirektoratet [cited 2014 24.02]. 
34. Luo, J., et al., Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, 
lung, and pancreas in male construction workers: a retrospective cohort study. Lancet, 
2007. 369(9578): p. 2015-20. 
35. Hatsukami, D.K., et al., Developing the science base for reducing tobacco harm. Nicotine 
Tob Res, 2007. 9 Suppl 4: p. S537-53. 
36. Folkehelseinstituttet [cited 2014 24.02]. 
37. Statistisk sentralbyrå [cited 2014 20.02]. 
38. Holm, H., et al., Nicotine intake and dependence in Swedish snuff takers. 
Psychopharmacology (Berl), 1992. 108(4): p. 507-11. 
39. Ebbert, J.O., et al., A Randomized Phase II Clinical Trial of High-Dose Nicotine Patch 
Therapy for Smokeless Tobacco Users. Nicotine Tob Res, 2013. 
40. Digard, H., et al., Determination of nicotine absorption from multiple tobacco products 
and nicotine gum. Nicotine Tob Res, 2013. 15(1): p. 255-61. 
41. Gartner, C.E., et al., Assessment of Swedish snus for tobacco harm reduction: an 
epidemiological modelling study. Lancet, 2007. 369(9578): p. 2010-4. 
42. Ebbert, J., et al., Interventions for smokeless tobacco use cessation. Cochrane Database 
Syst Rev, 2011(2): p. CD004306. 
43. Jones, B.F., A reappraisal of the use of infrared thermal image analysis in medicine. 
IEEE Trans Med Imaging, 1998. 17(6): p. 1019-27. 
44. Johnson, J.M., C.T. Minson, and D.L. Kellogg, Jr., Cutaneous vasodilator and 
vasoconstrictor mechanisms in temperature regulation. Compr Physiol, 2014. 4(1): p. 33-
89. 
45. Charkoudian, N., Skin blood flow in adult human thermoregulation: how it works, when it 




46. Miland, Å.O., Dynamic Infrared Thermography in the assessment of skin perfusion- a 
clinical and experimental study 2008. 
47. Bornmyr, S., et al., Finger skin blood flow in response to indirect cooling in normal 
subjects and in patients before and after sympathectomy. Clin Physiol, 1998. 18(2): p. 
103-7. 
48. Choi, J.K., et al., Evaluation of mean skin temperature formulas by infrared 
thermography. Int J Biometeorol, 1997. 41(2): p. 68-75. 
49. Love, T.J., Thermography as an indicator of blood perfusion. Ann N Y Acad Sci, 1980. 
335: p. 429-37. 
50. Weum, S., Imaging in plastic surgery- Aclinical and experimental study with notes on the 
history of medical imaging 2013. 
51. Stikbakke, E.a.M.J.B., An infrared thermographic and laser Doppler flowmetric 
investigation of skin perfusion in the forearm and finger tip following a short period of 
vascular stasis. Thermology International, 2008. 18: p. 4. 
52. Soler, N.G., Laboratory Evaluation of the Autonomic System, in Clinical Methods: The 
History, Physical, and Laboratory Examinations, H.K. Walker, W.D. Hall, and J.W. 
Hurst, Editors. 1990: Boston. 
53. Jeannette Naish, P.R., and Denise Syndercombe Court, Medical Sciences. 1 ed. 2009: 
Elsevier. 
54. FG, V.A.N.H., L. Kadic, and J.J. Driessen, Skin temperature measured by infrared 
thermography after ultrasound-guided blockade of the sciatic nerve. Acta Anaesthesiol 
Scand, 2013. 57(9): p. 1111-7. 
55. Miland, A.O. and J.B. Mercer, Effect of a short period of abstinence from smoking on 
rewarming patterns of the hands following local cooling. Eur J Appl Physiol, 2006. 98(2): 
p. 161-8. 
56. Taylor, W.F., et al., Effect of high local temperature on reflex cutaneous vasodilation. J 
Appl Physiol Respir Environ Exerc Physiol, 1984. 57(1): p. 191-6. 
57. Grassi, G., et al., Mechanisms responsible for sympathetic activation by cigarette smoking 
in humans. Circulation, 1994. 90(1): p. 248-53. 
58. Narkiewicz, K., et al., Cigarette smoking increases sympathetic outflow in humans. 
Circulation, 1998. 98(6): p. 528-34. 
59. Ring, E.F.J., The development of thermometry and thermal imaging in medicine. Journal 
of Medical Engineering & Technology, 2006. 
60. Ring, E.F. and K. Ammer, Infrared thermal imaging in medicine. Physiol Meas, 2012. 
33(3): p. R33-46. 
61. de Weerd, L., J.B. Mercer, and S. Weum, Dynamic infrared thermography. Clin Plast 
Surg, 2011. 38(2): p. 277-92. 
62. John, E.H.a.A.C.G., Guyton and Hall Textbook of Medical Physiology 12 ed. 2011: 
Saunders. 
63. Hall, J., Guyton and Hall Physiology Review (Guyton Physiology). 11th ed. 2011: 
Elsevier. 
64. Engineering, D.O. 2012  [cited 2014 02.05]. 
65. de Weerd, L., Free Perforator Flap surgery and Dymanic infrared Thermography- a 




66. (ISO), I.S.O., Medical electrical equipment -- Part 2-59: Particular requirements for 
basic safety and essential performance of screening thermographs for human febrile 
temperature screening, 2014. 
67. Smith, K.J.H.a.R.E., Guidelines for specifying and testing a thermal camera for medical 
applications Thermology International, 2009. 19. 
68. Hsieh, J.C., et al., Clinical application of infrared thermography in diagnosis and 
therapeutic assessment of vascular ischemic pain. Ma Zui Xue Za Zhi, 1990. 28(4): p. 
493-501. 
69. Bruehl, S., et al., Validation of thermography in the diagnosis of reflex sympathetic 
dystrophy. Clin J Pain, 1996. 12(4): p. 316-25. 
70. Bergqvist, D., H.O. Efsing, and T. Hallbook, Thermography. A noninvasive method for 
diagnosis of deep venous thrombosis. Arch Surg, 1977. 112(5): p. 600-4. 
71. Hooshmand, H., The role of infrared thermography in diagnosis and management of pain, 
in Engineering in Medicine and Biology Society. Proceedings of the 19th Annual 
International Conference of the IEEE  (Volume:2 )1997: Chicago, IL. 
72. Howell, K.J., Infrared thermography (IRT) for the assessement of microvascular skin 
blood flow in a specialist connective tissue diseasi unit, 2010, University of 
Glamorgan/Prifysgol Morgannwg. 
73. Ammer, E.F.R.R.a.K., Infrared thermal imaging in medicine Physiol Meas, 2012. 33: p. 
13. 
74. Pascoe, D.D., Ring, E.F., Mercer, J.B., Snell, J., Osborn, D.,  Hedley-Whyte, J.,, Clinical 
Thermometers, Project Team 1, Thermal Imagers for Human Febrile Temperature 
Screening (2010). . International Standards for Pandemic Screening Using Infrared 
Thermography. In: Proceedings of  SPIE Medical Imaging meeting., 2010. 7626 76261Z-
6. 
75. Herry, C.L. and M. Frize, Quantitative assessment of pain-related thermal dysfunction 
through clinical digital infrared thermal imaging. Biomed Eng Online, 2004. 3(1): p. 19. 
76. Rustemeyer, J., J. Radtke, and A. Bremerich, Thermography and thermoregulation of the 
face. Head Face Med, 2007. 3: p. 17. 
77. Uematsu, S., et al., Quantification of thermal asymmetry. Part 2: Application in low-back 
pain and sciatica. J Neurosurg, 1988. 69(4): p. 556-61. 
78. Walpole R.E, M.R.H., Myers S.L, Ye K Probability & Statistics, For engineers and 
Scientists 2007: Person Education International  
79. Trap-Jensen, J., Effects of smoking on the heart and peripheral circulation. Am Heart J, 
1988. 115(1 Pt 2): p. 263-7. 
80. Marrakchi, S. and H.I. Maibach, Biophysical parameters of skin: map of human face, 
regional, and age-related differences. Contact Dermatitis, 2007. 57(1): p. 28-34. 
81. Poore, T.K., et al., The effects of smokeless tobacco on clinical parameters of 
inflammation and gingival crevicular fluid prostaglandin E2, interleukin-1 alpha, and 
interleukin-1 beta. J Periodontol, 1995. 66(3): p. 177-83. 
82. Johnson, G.K., et al., Development of smokeless tobacco-induced oral mucosal lesions. J 
Oral Pathol Med, 1998. 27(8): p. 388-94. 
83. Kashima, H. and N. Hayashi, Facial skin blood flow responses to irritant stimuli in the 
oral cavity. Auton Neurosci, 2013. 174(1-2): p. 61-5. 
84. Kashima, H., Y. Hamada, and N. Hayashi, Palatability of tastes is associated with facial 




85. Lang, J., Clinical Anatomy of the Nose, Nasal Cavity and Paranasal Sinuses. 1989, New 
York Thieme. 
86. Mercer, P.J., 2014. 
87. John W. Castellani, P.D.C.O.B., M.S. , Peripheral Vasodilation Responses to Prevent 
Local Cold Injuries Meeting Proceedings RTO-MP-HFM-126, Keynote 2. Neuilly-sur-
Seine, France: RTO, 2005. 
88. Krogstad, A.L., et al., Arteriovenous anastomoses and the thermoregulatory shift between 
cutaneous vasoconstrictor and vasodilator reflexes. J Auton Nerv Syst, 1995. 53(2-3): p. 
215-22. 
89. Benowitz, N.L., et al., Interindividual variability in the metabolism and cardiovascular 
effects of nicotine in man. J Pharmacol Exp Ther, 1982. 221(2): p. 368-72. 
90. Kyerematen, G.A., et al., Smoking-induced changes in nicotine disposition: application of 
a new HPLC assay for nicotine and its metabolites. Clin Pharmacol Ther, 1982. 32(6): p. 
769-80. 
91. Daanen, D.H.A.M., Arterio-venous anastomoses and thermoregulation, in TNO Institute 
for Perception,Group: Thermophysiology1991. 
92. Dias, D.T., et al., Thermal characterization in vitro of human nail: photoacoustic study of 
the aging process. Photochem Photobiol, 2007. 83(5): p. 1144-8. 
93. Sorensen, L.T., et al., Smoking as a risk factor for wound healing and infection in breast 
cancer surgery. Eur J Surg Oncol, 2002. 28(8): p. 815-20. 
94. James B. Mercer, L.d.W., Åshild Odden Miland and Sven Weum Pre-, intra-, and 
postoperative use of dynamic infraredthermography (DIRT) provides valuable 
information on skin perfusion in perforator flaps used in reconstructive surgery. FLIR 
Technical Series Application Note for Research & Science Pre-, intra-, and postoperati, 
2010. 
95. Alimohammadi, H. and W.L. Silver, Evidence for nicotinic acetylcholine receptors on 
nasal trigeminal nerve endings of the rat. Chem Senses, 2000. 25(1): p. 61-6. 
96. Tang, J.S. and E.A. Kiyatkin, Fluctuations in central and peripheral temperatures 
induced by intravenous nicotine: central and peripheral contributions. Brain Res, 2011. 
1383: p. 141-53. 
97. Quick, M.W. and R.A. Lester, Desensitization of neuronal nicotinic receptors. J 
Neurobiol, 2002. 53(4): p. 457-78. 
98. Nyberg, G., et al., Cardiovascular effect of nicotine chewing gum in healthy non-smokers. 
Eur J Clin Pharmacol, 1982. 23(4): p. 303-7. 
99. Foulds, J. and L. Kozlowski, Snus--what should the public-health response be? Lancet, 
2007. 369(9578): p. 1976-8. 
100. Bates, C., et al., European Union policy on smokeless tobacco: a statement in favour of 
evidence based regulation for public health. Tob Control, 2003. 12(4): p. 360-7. 
101. Rodu, B. and P. Cole, Smokeless tobacco use and cancer of the upper respiratory tract. 
Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2002. 93(5): p. 511-5. 
102. Rodu, B. and C. Jansson, Smokeless tobacco and oral cancer: a review of the risks and 
determinants. Crit Rev Oral Biol Med, 2004. 15(5): p. 252-63. 
 
 
